Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06474299 · ClinicalTrials.gov registry record · Phase 4
The Avenues Study: Dual Use Cessation
A Phase 4 study of Smoking Cessation and Electronic Cigarette Use, sponsored by University of Wisconsin, Madison.
- Recruiting
- Registry status
- Phase 4
- Development phase
- 500
- Enrollment target
- 1
- Study location
NCT06474299 is a Phase 4 study of Smoking Cessation and Electronic Cigarette Use that is actively recruiting participants, run by University of Wisconsin, Madison. The registered enrollment target is 500 participants, roughly in line with the 472-participant average among 188 other Smoking Cessation trials with a reported enrollment target. The trial reports 1 study location across 1 state.
The verdict
NCT06474299, a Phase 4 study of Smoking Cessation and Electronic Cigarette Use, is actively recruiting participants, sponsored by University of Wisconsin, Madison.
- RECRUITING
- Registry status
- Phase 4
- Development phase
- 500 participants
- Enrollment target
- 1
- Study location
Study Summary
The overarching goal of this research is to determine the most effective approach for helping dual users of cigarettes and electronic nicotine delivery systems (ENDS) quit smoking. 500 participants will be enrolled and can expect to be on study for 12 months.
Conditions Studied
Interventions
- DRUG Varenicline
- DRUG Nicotine patch
- BEHAVIORAL Dual Focused Cessation Counseling
- BEHAVIORAL Smoking Focused Cessation Counseling
- OTHER Counseling Intensity: 1 Session
Study Locations (1)
Wisconsin
- University of Wisconsin-Madison School of Medicine and Public Health - Madison
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 500 participants |
| Start Date | 2024-09-24 |
| Est. Completion | 2028-07 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06474299
The ClinicalTrials.gov registry entry for NCT06474299 describes a study currently listed as recruiting, categorized as Phase 4. The registered enrollment target is 500 participants, a figure that helps gauge the scale of data the investigators plan to collect, roughly in line with the 472-participant average among 188 other Smoking Cessation trials with a reported enrollment target. The listed sponsor is University of Wisconsin, Madison, which has 1,039 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Smoking Cessation appearing as the primary indexed condition, and to 5 interventions - of which Varenicline is the first listed.
NCT06474299 reports 1 study location spanning 1 distinct geographic area - top geographies include Wisconsin.
Frequently Asked Questions
What is clinical trial NCT06474299 about?
NCT06474299 is a clinical study titled "The Avenues Study: Dual Use Cessation". The overarching goal of this research is to determine the most effective approach for helping dual users of cigarettes and electronic nicotine delivery systems (ENDS) quit smoking. 500 participants will be enrolled and can expect to be on study for 12 months.
What is the current status of trial NCT06474299?
This trial is currently recruiting. It is a Phase 4 study. The enrollment target is 500 participants. The study started on 2024-09-24. Estimated completion is 2028-07.
What conditions does trial NCT06474299 study?
This clinical trial studies the following conditions: Smoking Cessation, Electronic Cigarette Use.
What interventions are being tested in trial NCT06474299?
The interventions under investigation include: Varenicline (DRUG), Nicotine patch (DRUG), Dual Focused Cessation Counseling (BEHAVIORAL), Smoking Focused Cessation Counseling (BEHAVIORAL), Counseling Intensity: 1 Session (OTHER).
Who is sponsoring clinical trial NCT06474299?
This trial is sponsored by University of Wisconsin, Madison, which has 1,039 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06474299 being conducted?
This trial has 1 study location across Wisconsin. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Smoking Cessation
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Modifying Progesterone and Estradiol Levels to Prevent Postpartum Cigarette Smoking Relapse and Reduce Secondhand Smoke Exposure in Infants and Children
RECRUITING · Phase 4
-
The Options 2 Study
RECRUITING · Phase 4
-
Smoking Cessation Program in the Construction Sector
RECRUITING · Phase 4
-
Using Multiphase Optimization Strategy (MOST) to Optimize a Cost-effective, Sustainable and Scalable Smoking Cessation Package for Smokers in HIV Clinical Care
RECRUITING · Phase 4
-
Implementing Tobacco Treatment in Low Dose CT Lung Cancer Screening Sites
ACTIVE NOT RECRUITING · Phase 4
-
Informing Tobacco Treatment Guidelines for African American Non-Daily Smokers
COMPLETED · Phase 4
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.